Literature DB >> 27014652

Antihypertensive and antioxidant effects of hydroalcoholic extract from the aerial parts of Kelussia odoratissima Mozaff. in dexamethasone-induced hypertensive rats.

Leila Safaeian1, Seyed Ebrahim Sajjadi2, Shaghayegh Haghjoo Javanmard3, Hadi Gholamzadeh1.   

Abstract

BACKGROUND: Kelussia odoratissima Mozaff. is a monotypic endemic plant of Apiaceae growing wild in Iran. The aerial parts of this plant are used for treatment of hypertension, ulcer, and inflammatory conditions in folk medicine. In this study, the effects of hydroalcoholic extract of the aerial parts of K. odoratissima were evaluated in dexamethasone (Dex)-induced hypertension in male Wistar rats.
MATERIALS AND METHODS: For induction of hypertension, Dex (30 μg/kg/day) was administered subcutaneously for 14 days. In a prevention study, rats received oral K. odoratissima extract (100, 200, and 400 mg/kg) from 4 days before Dex administration and during the test period (days 1-18). In a reversal study, K. odoratissima extract was administered orally from day 8 to 14. Systolic blood pressure (SBP) was evaluated using tail-cuff method. The hydrogen peroxide (H2O2) concentration and ferric-reducing antioxidant power (FRAP) were measured in plasma samples.
RESULTS: Administrations of Dex significantly induced an increase in SBP and in plasma H2O2 and a decrease in body and thymus weights, and in FRAP value (P < 0.001). K. odoratissima extract dose-dependently prevented and reversed hypertension (P < 0.001). It also prevented and reduced the plasma H2O2 concentration and prevented the body weight loss upon Dex administration at all doses (100-400 mg/kg, P < 0.001) but failed to improve FRAP value.
CONCLUSIONS: These results suggest antihypertensive and antioxidant effects of K. odoratissima extract in Dex-induced hypertension. Further studies are needed to elucidate the exact mechanism of the antihypertensive effect of this herbal medicine.

Entities:  

Keywords:  Antioxidant activity; Kelussia odoratissima Mozaff; dexamethasone; hypertension

Year:  2016        PMID: 27014652      PMCID: PMC4785786          DOI: 10.4103/2277-9175.176342

Source DB:  PubMed          Journal:  Adv Biomed Res        ISSN: 2277-9175


INTRODUCTION

Hypertension is one of the most common cardiovascular risk factor and a main public health issue, which accounts for developing critical damage in major end-organs. The sustained high blood pressure is considered responsible for many serious medical conditions such as arteriosclerosis, heart failure, kidney failure, blindness, and cognitive impairment, and also for many deaths from stroke and heart disease.[1] The prevalence of hypertension is increasing worldwide and in spite of various pharmacological treatments, hypertension remains inadequately managed.[2] Moreover, the use of conventional antihypertensive drugs is often limited because of many side effects. Therefore, recent efforts have focused on herbal medicines for treatment of hypertension.[3] Kelussia odoratissima Mozaff., also named Amirkabiria odoratissima, belongs to the Apiaceae family whose species are considered as the well-known sources for functional foods and natural medicines. This family possesses mostly aromatic plants with important chemical constituents including essential oils, coumarins, polyacetylenes, flavonoids, sesquiterpenes, and phthalides.[456] K. odoratissima is a monotypic endemic plant of Apiaceae, only growing in Iran with common name of “Karafs-e-koohi” or “keloss.”[7] The aerial parts of this plant have a unique tasty smell and are used as a popular spice.[8] In folk medicine, K. odoratissima is used as a sedative plant and also for treatment of hypertension, ulcer, and inflammatory conditions.[9] Some pharmacological activities including antioxidant, anti-flatulence and stomach tonic, antibacterial, analgesic, anti-inflammatory, and sedative properties have been reported for K. odoratissima.[910111213] This plant also possesses beneficial cardiovascular properties such as anti-atherosclerotic effects because of fibrinolytic activity and its ability to inhibit lipid oxidation and to reduce total and low-density lipoprotein (LDL) cholesterol levels and C-reactive protein levels.[1415] Because there is no pharmacological study on anti-hypertensive activity of K. odoratissima, the present study was designed to evaluate the effects of chronic administration of K. odoratissima on hypertension and oxidative status in dexamethasone (Dex)-induced hypertensive rats.

MATERIALS AND METHODS

Animals

Male Wistar rats (200 ± 20 g) were obtained from the animal house of the School of Pharmacy and Pharmaceutical Sciences (Isfahan, Iran). The animals were housed under standard laboratory conditions with a 12 h light/12 h dark cycle. They had free access to tap water and standard pellet diet. The whole experiments were according to the international guidelines for laboratory animal use and care.

Chemicals

Dexamethasone was purchased from Darou Pakhsh Pharmaceutical Co. (Tehran, Iran) and captopril was obtained from Tehran Darou Pharmaceutical Co. (Tehran, Iran). Folin–Ciocalteu reagents were obtained from Merck Co. (Mumbai, India). The standard assay kits (Hakiman Shargh Research Co., Isfahan, Iran) were used for measurement of plasma hydroperoxides and ferric-reducing antioxidant power (FRAP) assay.

Plant material and preparation of extract

The aerial parts of K. odoratissima were collected from the central Zagros Mountain, Charmahal Bakhtiari province, in west of Iran, during March 2013. After verification of plant identity, a voucher specimen (No. 2022) was deposited at the Herbarium of the School of Pharmacy and Pharmaceutical Sciences, Isfahan, Iran. For preparation of hydroalcoholic extract, the air-dried aerial parts of the plant were powdered and extracted with ethanol (70%), using maceration method for 72 h, three times at room temperature. The solvent was removed by a rotary evaporator (Bibby RE200, UK) under pressure at 50°C to yield a viscous residue. Then the extract was freeze-dried and stored at − 20°C. The yield of the plant extract was 13.3% (w/w). Different concentrations of the extract were prepared in normal saline and 0.5% Tween 80 and desirable doses were administered orally in a volume of 0.1 ml/10 g body weight of rats.

Determination of total phenolic content

The phenolic compounds have an important role in the quality and nutritional value and also in antioxidant activity of plants. The total phenol content of the plant extract was measured colorimetrically using the Folin–Ciocalteu method.[16] Briefly, the plant sample was mixed with Na2CO3 (20%) and treated with diluted Folin–Ciocalteu's phenol reagent and the absorbance was measured at 765 nm using a UV spectrophotometer. The total phenol content was estimated by comparison with a standard curve generated from different concentrations of gallic acid and was expressed as gallic acid equivalents (GAE) per gram of the plant.

Experimental protocol

To induce hypertension, rats received subcutaneously (s.c.) injection of Dex (30 μg/kg/day) for 14 days.[17] In the saline control group, animals received daily injection of saline (1 mL/kg, s.c.). In a prevention study, rats received oral K. odoratissima extract (100, 200, and 400 mg/kg) or captopril (40 mg/kg, as an antihypertensive positive control) using an intragastric tube from 4 days before Dex administration and during the test period (days 1–18). In the reversal study, K. odoratissima extract or captopril was administered from day 8 to 14. Six animals were used in each control and experimental groups. All rats were weighed on alternate days. Animals were sacrificed at the end of the experiment under ether anesthesia. The thymus gland was removed and weighed. Blood was collected and plasma samples were stored at −80°C for further experiments.

Measurement of systolic blood pressure

The systolic blood pressure (SBP) was measured by noninvasive tail-cuff method (AD Instrument PowerLab Data Acquisition System, Sydney, Australia) at the first day and the last day of the experiment (days 1 and 18) in conscious rats. The animals were restrained in heated chambers at 38 ± 1°C for 10 min. Rats were trained with blood pressure measuring equipment for one week before initiation of the experiment. Blood pressure was recorded at least three times for each rat and averaged to obtain a mean SBP.

Measurement of thymus weight

The thymus gland weight, as a marker of glucocorticoid activity was expressed relative to body weight (mg/100 g of body weight).[18]

Measurement of plasma hydrogen peroxide concentration

For measurement of plasma hydrogen peroxide (H2O2) concentration, the assay was based on the ferrous ion oxidation by xylenol orange reagent in aqueous medium with sorbitol (FOX1).[19] In brief, FOX1 reagent prepared according to the manufacturer's protocol was mixed with plasma samples. After incubation for 30 min in 37°C, the absorbance of solutions was measured at 540 nm using a microplate reader/spectrophotometer (Bio-Tek, PowerWave XS, Wincoski, USA). The H2O2 concentration of plasma samples was estimated using a standard curve generated from different concentrations of hydrogen peroxide.

Measurement of plasma ferric-reducing antioxidant power

The total antioxidant capacity of plasma samples was determined based on FRAP assay.[20] FRAP values were evaluated based on the reduction of ferric-tripyridyltriazine complex to ferrous form. In brief, the FRAP reagent prepared according to the manufacturer's protocol was added to plasma samples. After incubation for 40 min in 40°C, the absorbance of colored solutions was measured at 570 nm using a microplate reader/spectrophotometer. The FRAP values of samples were estimated against the standard curve of FeSO4 × 7H2O concentration and reported as micromole of FeII equivalents per liter.

Statistical analysis

Results were expressed as the mean ± standard error of mean. Statistical analysis was done by one-way analysis of variance followed by Tukey post hoc test using SPSS software version 16.0. The graph of thymus weight data were drawn using GraphPad-Prism software version 5. P values < 0.05 were used as the criteria for significant differences.

RESULTS

Total phenolic content

The total phenolic content assay showed 15 ± 0.03 mg GAE/g of the dried aerial parts of K. odoratissima extract.

Effect of K. odoratissima extract on blood pressure

Figure 1 shows the effect of pretreatment with K. odoratissima extract (100, 200, and 400 mg/kg) and captopril (40 mg/kg) on SBP in Dex-induced hypertension. The blood pressure significantly increased from 117.8 ± 1.5 to 144.6 ± 2.1 mmHg on day 18 in Dex-treated rats (P < 0.001) in comparison with saline control group (113.7 ± 2.5 mmHg). Pretreatment with captopril and K. odoratissima extract at doses of 200 and 400 mg/kg significantly prevented the increase in SBP (P < 0.001) [Figure 1]. In reversal study, administration of K. odoratissima extract at dose of 400 mg/kg lowered the SBP in Dex-induced hypertensive rats (P < 0.001) [Figure 2].
Figure 1

Effects of Kelussia odoratissima extract (100–400 mg/kg) and captopril (40 mg/kg) on systolic blood pressure in Dex-induced hypertension in prevention groups. Values are means + SEM for six rats. ##P < 0.01 and ###P < 0.001 versus saline control group, ***P < 0.001 versus Dex control group

Figure 2

Effects of Kelussia odoratissima extract (100–400 mg/kg) and captopril (40 mg/kg) on systolic blood pressure in Dex-induced hypertension in reversal groups. Values are means + SEM for six rats. ##P < 0.01 and ###P < 0.001 versus saline control group, ***P < 0.001 versus Dex control group

Effects of Kelussia odoratissima extract (100–400 mg/kg) and captopril (40 mg/kg) on systolic blood pressure in Dex-induced hypertension in prevention groups. Values are means + SEM for six rats. ##P < 0.01 and ###P < 0.001 versus saline control group, ***P < 0.001 versus Dex control group Effects of Kelussia odoratissima extract (100–400 mg/kg) and captopril (40 mg/kg) on systolic blood pressure in Dex-induced hypertension in reversal groups. Values are means + SEM for six rats. ##P < 0.01 and ###P < 0.001 versus saline control group, ***P < 0.001 versus Dex control group

Effect of K. odoratissima extract on thymus weight

After Dex injection, the thymus gland weight significantly decreased in hypertensive rats (P < 0.001) but administration of K. odoratissima extract and captopril could not prevent the thymus weight decrease [Figure 3].
Figure 3

Effects of administration of Kelussia odoratissima (400 mg/kg) and captopril (40 mg/kg) on thymus weight in Dex-induced hypertension in prevention (Prev) and reversal (Rev) groups. Values are means for six rats

Effects of administration of Kelussia odoratissima (400 mg/kg) and captopril (40 mg/kg) on thymus weight in Dex-induced hypertension in prevention (Prev) and reversal (Rev) groups. Values are means for six rats

Effect of K. odoratissima extract on body weight

The body weight significantly decreased during Dex injection in hypertensive rats when compared with saline control group (P < 0.001). Administration of K. odoratissima extract at all doses improved weight gaining in rats but captopril could not prevent weight loss induced by dexamethasone [Figure 4].
Figure 4

Effects of Kelussia odoratissima extract (400 mg/kg) and captopril (40 mg/kg) on body weight in Dex-induced hypertension. Values are means + SEM for six rats. #P < 0.05, ##P < 0.01 and ###P < 0.001 versus saline control group, *P < 0.05, **P < 0.01 and ***P < 0.001 versus Dex control group

Effects of Kelussia odoratissima extract (400 mg/kg) and captopril (40 mg/kg) on body weight in Dex-induced hypertension. Values are means + SEM for six rats. #P < 0.05, ##P < 0.01 and ###P < 0.001 versus saline control group, *P < 0.05, **P < 0.01 and ***P < 0.001 versus Dex control group

Effect of K. odoratissima extract on plasma H2O2 concentration

In Dex-treated group, the level of plasma H2O2 was significantly higher than saline control group (P < 0.001). Administration of captopril and K. odoratissima extract at all doses significantly (P < 0.001) prevented the rise in H2O2 concentration in prevention study and reduced the elevated plasma H2O2 concentration in reversal study (P < 0.001). At a dose of 400 mg/kg of K. odoratissima, the plasma H2O2 concentration was also significantly lower than saline control group [Figure 5].
Figure 5

Effects of Kelussia odoratissima extract (100–400 mg/kg) and captopril (40 mg/kg) on plasma H2O2 concentration on Dex-induced hypertension in prevention (Prev) and reversal (Rev) groups. Values are means + SEM for six rats. ##P < 0.01 and ###P < 0.001 versus saline control group, ***P < 0.001 versus Dex control group

Effects of Kelussia odoratissima extract (100–400 mg/kg) and captopril (40 mg/kg) on plasma H2O2 concentration on Dex-induced hypertension in prevention (Prev) and reversal (Rev) groups. Values are means + SEM for six rats. ##P < 0.01 and ###P < 0.001 versus saline control group, ***P < 0.001 versus Dex control group

Effect of K. odoratissima extract on plasma FRAP value

In Dex-induced hypertensive rats, the plasma FRA P value was significantly lower than saline control group (P < 0.001). Administration of captopril and K. odoratissima extract had no significant effect on the FRAP value in prevention and reversal groups [Figure 6].
Figure 6

Effects of Kelussia odoratissima extract (100–400 mg/kg) and captopril (40 mg/kg) on plasma FRAP value on Dex-induced hypertension in prevention (Prev) and reversal (Rev) groups. Values are means + SEM for six rats. ###P < 0.001 versus saline control group

Effects of Kelussia odoratissima extract (100–400 mg/kg) and captopril (40 mg/kg) on plasma FRAP value on Dex-induced hypertension in prevention (Prev) and reversal (Rev) groups. Values are means + SEM for six rats. ###P < 0.001 versus saline control group

DISCUSSION

The results of the present study showed antihypertensive and antioxidant effects of K. odoratissima extract in Dex-induced hypertension. Administration of K. odoratissima extract dose-dependently prevented and reversed a rise in SBP and also reduced the plasma H2O2 concentration and prevented the body weight loss upon Dex administration. During chronic use of glucocorticoids such as dexamethasone, hypertension develops as a result of increased activity of renin–angiotensin, endothelin and sympathetic systems, and hemodynamic alterations.[21] Glucocorticoid–induced hypertension is also associated with increased oxidative stress and overproduction of reactive oxygen species (ROS), which interacts with NO and contributes to NO deficiency and vasoconstriction.[22] Increased production of ROS in vasculature is predominantly caused through NAPDH oxidase pathway in Dex-induced hypertension.[23] Some antioxidant agents have been found to prevent and attenuate hypertension from Dex.[2425] The beneficial effects of some traditional herbal medicine have been also reported for the management of hypertension; however, their usage needs scientific confirmation and validation.[3] K. odoratissima Mozaff. is a plant with nutritional and medicinal applications. Phytochemical analysis of K. odoratissima extract has shown the presence of flavonols, caffeic acid, rutin, ferulic acid, and phthalides.[89101112131415] The major constituent of the volatile oils of this herb is 3-butylidene-4,5-dihydrophthalide (z-ligustilide), and also other phthalides including cis-3-butylidene phthalide and 3-n-butyl phthalide.[13] The presence of these effective components may be involved in the antioxidant and antihypertensive properties of K. odoratissima. Phthalides are known as the bioactive phytochemicals occurring in some species of Apiaceae family.[26] Various biological activities have been established for ligustilide such as antioxidant, vascular smooth muscle relaxation, improved microcirculation actions, or effects on central noradrenergic and/or GABA systems.[272829] Ligustilide has shown a vasodilator effect on rat abdominal aorta by inhibition of noradrenaline.[30] It has resulted in vasodilatation of rat mesenteric artery through blockade of voltage-dependent and receptor-operated calcium channels.[29] The results of investigations have also demonstrated the hypotensive and vasorelaxant effects of 3-n-butyl phthalide possibly through blockade of calcium channels.[31] Flavonols are polyphenolic antioxidant compounds, which are widely distributed in plants and have beneficial cardiovascular effects. Some flavonols produce an antihypertensive effect through endothelium-independent vasodilation action and have vascular protective effect under oxidative stress conditions.[32] Other constituents of K. odoratissima extract are cinnamic acid compounds including caffeic acid and ferulic acid. Caffeic acid is a phenolic acid with ability to reduce the risk of cardiovascular disorders. It has been found that caffeic acid reduces the proliferative reaction of vascular smooth muscle cell to angiotensin II in hypertensive rats by inhibiting the production of ROS and blocking the JAK/STAT signaling cascade and the Ras/Raf-1/ERK1/2 cascade.[33] Ferulic acid is a phenolic compound with antihypertensive effects, which induces NO-mediated vasodilation and improvement of structure and function and antioxidant status of the heart, blood vessels, liver, and kidneys in hypertensive rats.[3435] Both of caffeic acid and ferulic acid also possess antagonist effects against endothelin-1 responses. They could blunt the blood pressure elevation and dilate the vasoconstriction of isolated aortic rings induced by endothelin-1.[36] The antioxidant effect of K. odoratissima extract may also account for its antihypertensive effects in Dex-induced hypertension. In this study, K. odoratissima extract reduced the plasma H2O2 concentration nevertheless failed to improve the total antioxidant capacity of the plasma. K. odoratissima has been introduced as a potential herbal source for preparing the effective medicines in oxidant-related diseases regarding its antioxidant activity and ability to reduce lipid peroxidation.[937] The results of several studies have also indicated the antioxidant effect of captopril. Captopril as an angiotensin-converting enzyme inhibitor was found to possess scavenging effects on hydroxyl radical and to protect erythrocyte membranes from lipid peroxidation.[38] It also possesses protective effect on tissues from oxidative damage by increasing enzymatic and nonenzymatic antioxidant defenses.[39]

CONCLUSION

In conclusion, this study showed the antihypertensive and antioxidant effects of hydroalcoholic extract of the aerial parts of K. odoratissima in Dex-induced hypertension. These findings provide validation and support for the use of this plant as folk medicine for the treatment of hypertension in Iran. Further investigations are still required for understanding the detailed mechanisms of antihypertensive effect of K. odoratissima extract.
  24 in total

1.  Oleanolic acid prevents glucocorticoid-induced hypertension in rats.

Authors:  Sagar S Bachhav; Savita D Patil; Mukesh S Bhutada; Sanjay J Surana
Journal:  Phytother Res       Date:  2011-02-24       Impact factor: 5.878

2.  Screening, analysis and in vitro vasodilatation of effective components from Ligusticum Chuanxiong.

Authors:  Ming-Jin Liang; Lang-Chong He; Guang-De Yang
Journal:  Life Sci       Date:  2005-09-08       Impact factor: 5.037

3.  Antioxidant and prooxidant properties of captopril and enalapril.

Authors:  M Bartosz; J Kedziora; G Bartosz
Journal:  Free Radic Biol Med       Date:  1997       Impact factor: 7.376

4.  Caffeic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II in stroke-prone spontaneously hypertensive rats.

Authors:  Peng-Gao Li; Jin-Wen Xu; Katsumi Ikeda; Akira Kobayakawa; Yasuyo Kayano; Takahiko Mitani; Takao Ikami; Yukio Yamori
Journal:  Hypertens Res       Date:  2005-04       Impact factor: 3.872

5.  Role of xanthine oxidase in dexamethasone-induced hypertension in rats.

Authors:  Sharon L H Ong; Janine J Vickers; Yi Zhang; Katja U S McKenzie; Claire E Walsh; Judith A Whitworth
Journal:  Clin Exp Pharmacol Physiol       Date:  2007 May-Jun       Impact factor: 2.557

6.  Enalapril and captopril enhance antioxidant defenses in mouse tissues.

Authors:  E M de Cavanagh; C G Fraga; L Ferder; F Inserra
Journal:  Am J Physiol       Date:  1997-02

Review 7.  The structural diversity of phthalides from the Apiaceae.

Authors:  John J Beck; Shen-Chieh Chou
Journal:  J Nat Prod       Date:  2007-05-04       Impact factor: 4.050

Review 8.  A systematic review of the potential herbal sources of future drugs effective in oxidant-related diseases.

Authors:  Shirin Hasani-Ranjbar; Bagher Larijani; Mohammad Abdollahi
Journal:  Inflamm Allergy Drug Targets       Date:  2009-03

9.  The role of 20-hydroxyeicosatetraenoic acid in adrenocorticotrophic hormone and dexamethasone-induced hypertension.

Authors:  Yi Zhang; Jason H Y Wu; Janine J Vickers; Sharon L H Ong; Suzanna E L Temple; Trevor A Mori; Kevin D Croft; Judith A Whitworth
Journal:  J Hypertens       Date:  2009-08       Impact factor: 4.844

10.  General cardiovascular risk profile for use in primary care: the Framingham Heart Study.

Authors:  Ralph B D'Agostino; Ramachandran S Vasan; Michael J Pencina; Philip A Wolf; Mark Cobain; Joseph M Massaro; William B Kannel
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.